These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18213899)

  • 1. [Molecular imaging for pharmacodynamics of psychotropic drugs].
    Suhara T
    Seishin Shinkeigaku Zasshi; 2007; 109(9):869-75. PubMed ID: 18213899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of PET in clinical trials of psychotropic drugs].
    Suhara T; Morimoto T
    Seishin Shinkeigaku Zasshi; 2005; 107(7):704-11. PubMed ID: 16250122
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of drug therapy based on the results of imaging].
    Suhara T
    Seishin Shinkeigaku Zasshi; 2004; 106(7):916-20. PubMed ID: 15478634
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular imaging in the drug development of psychotropics using positron emission tomography].
    Takano H; Takahashi H; Ito H; Suhara T
    Brain Nerve; 2007 Mar; 59(3):215-20. PubMed ID: 17370647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of psychotropic drugs.
    Serretti A
    Pharmacogenomics; 2011 Nov; 12(11):1509-10. PubMed ID: 22044410
    [No Abstract]   [Full Text] [Related]  

  • 6. Ex vivo and in vivo evaluation of [18F]PR04.MZ in rodents: a selective dopamine transporter imaging agent.
    Riss PJ; Debus F; Hummerich R; Schmidt U; Schloss P; Lueddens H; Roesch F
    ChemMedChem; 2009 Sep; 4(9):1480-7. PubMed ID: 19588472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.
    Mavel S; Vercouillie J; Garreau L; Raguza T; Ravna AW; Chalon S; Guilloteau D; Emond P
    Bioorg Med Chem; 2008 Oct; 16(19):9050-5. PubMed ID: 18793858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse.
    Ase AR; Reader TA; Hen R; Descarries L
    J Chem Neuroanat; 2008 Jul; 35(4):356-63. PubMed ID: 18406571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of variability in drug response and traditional approaches to dosage regimen design.
    Risch SC
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():237A-238A. PubMed ID: 1498825
    [No Abstract]   [Full Text] [Related]  

  • 10. At long last, long-lasting psychiatric medications: an overview of controlled-release technologies.
    Stahl SM
    J Clin Psychiatry; 2003 Apr; 64(4):355-6. PubMed ID: 12716234
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychotropic drugs for old and very old patients].
    Rümmele W
    Schweiz Rundsch Med Prax; 1982 Aug; 71(34):1317-9. PubMed ID: 7134180
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P
    Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity.
    Jørgensen S; Nielsen EØ; Peters D; Dyhring T
    J Neurosci Methods; 2008 Mar; 169(1):168-76. PubMed ID: 18222006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of D(2) and D(3) receptor activity in vivo: PET scan and prolactin.
    Thomasson-Perret N; Pénélaud PF; Théron D; Gouttefangeas S; Mocaër E
    Therapie; 2008; 63(3):237-42. PubMed ID: 18718212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal variation in human brain serotonin transporter binding.
    Praschak-Rieder N; Willeit M; Wilson AA; Houle S; Meyer JH
    Arch Gen Psychiatry; 2008 Sep; 65(9):1072-8. PubMed ID: 18762593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination of Na(+) by monoamine ligands in dopamine, norepinephrine, and serotonin transporters.
    Xhaard H; Backström V; Denessiouk K; Johnson MS
    J Chem Inf Model; 2008 Jul; 48(7):1423-37. PubMed ID: 18543980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The personality trait openness is related to cerebral 5-HTT levels.
    Kalbitzer J; Frokjaer VG; Erritzoe D; Svarer C; Cumming P; Nielsen FA; Hashemi SH; Baaré WF; Madsen J; Hasselbalch SG; Kringelbach ML; Mortensen EL; Knudsen GM
    Neuroimage; 2009 Apr; 45(2):280-5. PubMed ID: 19135154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D(3) receptor antagonists: The quest for a potentially selective PET ligand. Part two: Lead optimization.
    Micheli F; Holmes I; Arista L; Bonanomi G; Braggio S; Cardullo F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Terreni S; Heidbreder C; Savoia C; Griffante C; Worby A
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4011-3. PubMed ID: 19553113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
    McCormick PN; Kapur S; Reckless G; Wilson AA
    Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.